Citius Oncology (CTOR) Cash & Equivalents (2022 - 2026)
Citius Oncology (CTOR) reported Cash & Equivalents of $16.56 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with $112.00 a year earlier and up 529.2% from the prior quarter.
Powered by 
Analysis
Citius Oncology (CTOR) Cash & Equivalents (2022 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Citius Oncology posted Cash & Equivalents of $3.92 million.
- Cash & Equivalents has a three-year compound annual growth rate of 138.5% (FY2022 to FY2025).
- By fiscal year, Cash & Equivalents came in at $112.00 in FY2024, $32,746 in FY2023 (-88.7%) and $289,175 in FY2022.
- The fiscal Q3 2026 figure ranks as the highest quarterly Cash & Equivalents in data going back to fiscal Q4 2022.
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $2.63 million (Q2 2026), $7.3 million (Q1 2026) and $3.92 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Citius Oncology | 106.82 Mn | 106.82 Mn | 1.00 Mn | 16.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.56 Mn |
| Mar 31, 2026 | 2.63 Mn |
| Dec 31, 2025 | 7.30 Mn |
| Sep 30, 2025 | 3.92 Mn |
| Jun 30, 2025 | 112.00 |
| Mar 31, 2025 | 112.00 |
| Dec 31, 2024 | 112.00 |
| Sep 30, 2024 | 112.00 |
| Jun 30, 2024 | 261.00 |
| Mar 31, 2024 | 33,330.00 |
| Dec 31, 2023 | 32,746.00 |
| Sep 30, 2023 | 26,523.00 |
| Jun 30, 2023 | 370,095.00 |
| Mar 31, 2023 | 120,376.00 |
| Dec 31, 2022 | 289,175.00 |
API Access
Citius Oncology Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CTOR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CTOR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CTOR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();